drugset / Trial / NCT06344728
A Study to Assess the Relative Bioavailability of Brensocatib Pediatric Oral Solution to Oral Tablets in Healthy Participants
RandomizedCrossoverOpen-labelTreatment
Summary
The primary purpose of this study is to determine the relative bioavailability of brensocatib between the pediatric oral solution and oral tablets in healthy participants.
Timeline
- Start
- 2024-04-30
- Primary completion
- 2024-05-24
- Completion
- 2024-05-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Brensocatib | Small molecule | — | Oral |
Indications
No indication recorded.